Rhythm Pharmaceuticals reports $57M Q4 revenue, 50% annual growth
Go back to Rhythm Pharmaceuticals reports $57M Q4 revenue, 50% annual growth| (NASDAQ: RYTM) | Delayed: 104.82 +0.08 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $104.74 | 52 Week High | $ | |||
| Open | $105.50 | 52 Week Low | $ | |||
| Day High | $108.57 | P/E | N/A | |||
| Day Low | $103.95 | EPS | $ | |||
| Volume | 140,718 | |||||
